Global Regenerative Medicine Market Size study, by Technology (Stem Cell Therapy, Biomaterial, Tissue Engineering, Others), by Application (Bone Graft Substitutes, Osteoarticular Diseases, Dermatology, Cardiovascular, Central Nervous System, Others) and Regional Forecasts 2019-2026
- BIZ3199901
- 200 Pages
- June 2019
- Diagnostic and Biotech
Global Regenerative Medicine Market valued approximately USD 49.68 billion in 2018 is anticipated to grow with a healthy growth rate of more than 24.2% over the forecast period 2019-2026. The Regenerative Medicine Market is continuously growing in the global scenario at significant pace. Regenerative medicines are used to repair, replace, and regenerate tissues and organs affected by injury, disease, or natural aging process. These medicines restore the functionality of cells & tissues and are used in several degenerative disorders such as dermatology, neurodegenerative diseases, cardiovascular, and orthopedic applications. Stem cells are capable of proliferation and differentiation, which increase their importance in this field. Government & private funding to support the development of regenerative medicine, surging prevalence of chronic diseases & genetic disorders, escalating healthcare expenditure and rising geriatric population are the substantial driving factors of the market during the forecast period. Moreover, surging demand for organ transplantation and rising advancements in regenerative medicine is the factors that likely to create numerous opportunity in the near future. However, lack of clear regulatory guidelines and high cost of the treatment through the use of regenerative medicine are the factors that limiting the growth of the market during the forecast period.
The regional analysis of Global Regenerative Medicine Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share with nearly 31.3% due to rapid technological advancements and high investment & funding to support development of regenerative medicines in the region. Europe is also estimated to grow at stable growth rate in the global Regenerative Medicine market over the upcoming years. Further, Asia-Pacific is anticipated to exhibit higher growth rate / CAGR over the forecast period 2019-2026 due to rising development of healthcare infrastructure and presence of large number of patients in the region.
The major market player included in this report are:
Acelity L.P. Inc.
Nuvasive Inc.
Vericel Corporation
Osiris Therapeutics Inc.
Stryker Corporation
Medtronic PLC
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Technology:
Stem Cell Therapy
Biomaterial
Tissue Engineering
Others
By Application:
Bone Graft Substitutes
Osteoarticular Diseases
Dermatology
Cardiovascular
Central Nervous System
Others
By Regions:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026
Target Audience of the Global Regenerative Medicine Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
"Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Key Trends
1.3. Global & Segmental Market Estimates & Forecasts, 2016-2026 (USD Billion)
1.3.1. Regenerative Medicine Market, by Technology, 2016-2026 (USD Billion)
1.3.2. Regenerative Medicine Market, by Application, 2016-2026 (USD Billion)
1.3.3. Regenerative Medicine Market, by Region, 2016-2026 (USD Billion)
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Regenerative Medicine Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Regenerative Medicine Market Dynamics
3.1. See Saw Analysis
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Regenerative Medicine Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.2. PEST Analysis
4.2.1. Political Scenario
4.2.2. Economic Scenario
4.2.3. Social Scenario
4.2.4. Technological Scenario
4.3. Key Buying Criteria (On Demand)
4.4. Regulatory Framework (On Demand)
4.5. Investment Vs Adoption Scenario (On Demand)
4.6. Analyst Recommendation & Conclusion
Chapter 5. Regenerative Medicine Market, by Technology
5.1. Market Snapshot
5.2. Market Performance - Potential Model
5.3. Key Market Players
5.4. Regenerative Medicine Market, Sub Segment Analysis
5.4.1. Stem Cell Therapy
5.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
5.4.2. Biomaterial
5.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
5.4.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.4.3. Tissue Engineering
5.4.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
5.4.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.4.4. Others
5.4.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
5.4.4.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
Chapter 6. Regenerative Medicine Market, by Application
6.1. Market Snapshot
6.2. Market Performance - Potential Model
6.3. Key Market Players
6.4. Regenerative Medicine Market, Sub Segment Analysis
6.4.1. Bone Graft Substitutes
6.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
6.4.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.4.2. Osteoarticular Diseases
6.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
6.4.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.4.3. Dermatology
6.4.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
6.4.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.4.4. Cardiovascular
6.4.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
6.4.4.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.4.5. Central Nervous System
6.4.5.1. Market estimates & forecasts, 2016-2026 (USD Billion)
6.4.5.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.4.6. Others
6.4.6.1. Market estimates & forecasts, 2016-2026 (USD Billion)
6.4.6.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
Chapter 7. Regenerative Medicine Market, by Regional Analysis
7.1. Regenerative Medicine Market, Regional Market Snapshot (2016-2026)
7.2. North America Regenerative Medicine Market Snapshot
7.2.1. U.S.
7.2.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.2.1.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.2.1.3. Applications breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.2.2. Canada
7.2.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.2.2.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.2.2.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3. Europe Regenerative Medicine Market Snapshot
7.3.1. U.K.
7.3.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.3.1.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.1.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.2. Germany
7.3.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.3.2.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.2.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.3. Rest of Europe
7.3.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.3.3.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.3.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4. Asia Regenerative Medicine Market Snapshot
7.4.1. China
7.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.4.1.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.1.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.2. India
7.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.4.2.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.2.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.3. Japan
7.4.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.4.3.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.3.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.4. Rest of Asia Pacific
7.4.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.4.4.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.4.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.5. Latin America Regenerative Medicine Market Snapshot
7.5.1. Brazil
7.5.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.5.1.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.5.1.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.5.2. Mexico
7.5.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.5.2.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.5.2.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.6. Rest of The World
7.6.1. South America
7.6.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.6.1.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.6.1.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.6.2. Middle East and Africa
7.6.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.6.2.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.6.2.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
Chapter 8. Competitive Intelligence
8.1. Company Market Share (Subject to Data Availability)
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Acelity L.P. Inc.
8.3.1.1. Overview
8.3.1.2. Financial (Subject to Data Availability)
8.3.1.3. Summary
8.3.1.4. Recent Developments
8.3.2. Nuvasive Inc.
8.3.3. Vericel Corporation
8.3.4. Osiris Therapeutics Inc.
8.3.5. Stryker Corporation
8.3.6. Medtronic PLC
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.1.6. Research Assumption"
Similar Reports
Biomaterials are materials of either synthetic or natural origin that are used for interaction with biological systems for medical purposes such as treating or repairing damage tissues. They are used in joint replacements, plastic surgeries, drug delivery devi...
- Publish Date: September 1, 2016
- $5370
The global DNA sequencing market was estimated to be $6,243 million in 2017 and is projected to reach $25,470 million in 2025 growing with a CAGR of 19% from 2018 to 2025. DNA sequencing is a type of technology in which several DNA strands can be sequenced through massive parallelization. The DNA sequencing contains both Sanger’s method of sequencing and non-Sanger’s methods of sequencing. ...
- Publish Date: May 24, 2017
- $5370
Patients with serious nervous system injuries or strokes often require lifelong assistance, which burdens patients, their families, and society. Innovative, paradigm shifting strategies are required to develop treatments for neurological injury. Early dia...
- Publish Date: May 24, 2017
- $5370
